Safe use of hemodialysis for dabigatran removal before cardiac surgery.
about
Protocol in managing oral surgical patients taking dabigatranPharmacometric characterization of dabigatran hemodialysisPreventive strategies against bleeding due to nonvitamin K antagonist oral anticoagulants.Dabigatran: patient management in specific clinical settings.Management of non-vitamin K antagonist oral anticoagulants in the perioperative settingReversal of novel oral anticoagulants in patients with major bleeding.European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation.Enhanced elimination of dabigatran through extracorporeal methods.Bilateral Spontaneous Hyphema, Vitreous Hemorrhage, and Choroidal Detachment With Concurrent Dabigatran Etexilate TherapyClinical diseases with thrombotic risk and their pharmacologycal treatment: how they change the therapeutic attitude in dental treatments.Treatment of dabigatran-associated bleeding: case report and review of the literature.Thrombin inhibitors: surgical considerations and pharmacology.Dabigatran: is there a role for coagulation assays in guiding therapy?Dabigatran and kidney disease: a bad combination.Evaluation of dabigatran exposures reported to poison control centers.What is the role of renal replacement therapy in the setting of dabigatran toxicity?Oral anticoagulants and status of antidotes for the reversal of bleeding risk.Dabigatran excess: case report and review of the literature.Management of hemorrhage with the target-specific oral anticoagulants.Strategies for urgent reversal of target-specific oral anticoagulants.Use of Non-Vitamin K Antagonist Oral Anticoagulants in Special Patient Populations with Nonvalvular Atrial Fibrillation: A Review of the Literature and Application to Clinical Practice.Emergency Neurological Life Support: Pharmacotherapy.Who, when, and how to reverse non-vitamin K oral anticoagulants.Update on Anticoagulation: What the Interventional Radiologist Needs to Know.The epidemic of pre-injury oral antiplatelet and anticoagulant use.Comparison of intermittent and continuous extracorporeal treatments for the enhanced elimination of dabigatran.Idarucizumab (Praxbind) for reversal of pradaxa prior to emergent repair of contained ruptured transverse arch aneurysm.Venovenous haemodiafiltration for the management of dabigatran overdose in intensive care unit.Dabigatran etexilate for thromboembolic prophylaxis in non-valvular atrial fibrillation: the RE-LY study and substudies with commentary.Evaluation of dabigatran utilization and risk among hospitalized patients.
P2860
Q27006890-B2D02888-2E45-43DB-8AB6-94C0B062ADA2Q29584461-B18912C1-9D19-4195-9833-751F65CEB4F4Q33854667-B996E9B7-3A0E-493E-8575-37DBA6C4F9F1Q34196100-1B8F7264-5E91-4D95-9F15-4220900F172BQ34207558-7B35FC5B-C4AA-4626-8B87-B8B6BC80E6E1Q34326655-E55A63E8-97DB-445B-82DD-37319BC6CA2DQ34651051-BD12BAB0-6DB4-4271-8113-D06853D4AD89Q35210137-39B1C793-3011-4F35-B961-CEB6D243FD88Q35885429-1E42ED54-4B1E-47F0-9A4F-84319FC8183EQ37370565-7F8D2369-A6EB-4081-AADB-E868A7F12BACQ38060565-CA647FBA-D3F0-4795-88A1-0F91AF0661F3Q38079287-CF9F7BC7-AD8F-41C5-AE13-1519D6329C93Q38106833-817BEC2C-0586-4BC0-A55A-416746FB7876Q38122675-C65CCDAB-4BBD-4639-ACD2-AB48A4FEE288Q38168479-C7B052C3-E241-4568-8F9C-A54BDA1E2A76Q38195315-A0978734-B946-4F5F-AADA-5CF2AC6964F6Q38239244-05C0269F-C177-4B60-BDED-4FF05AB79B73Q38241091-501B4B70-B9FA-43CD-9C7F-9C60A7482F3BQ38254250-CF529D87-47F0-44C6-80FC-0D542D0BD06DQ38285105-A297E211-553B-41AC-A420-082D35DE3993Q38496232-2C9E5B98-56AE-4F28-97C6-9C34757C31DCQ38599737-0F28CF9F-B91A-4376-A636-A47BEB9C8330Q38655960-812820A0-DC6B-4F8C-85CE-396A1F45EBB1Q38849824-2B590800-5606-4300-96FD-FD0C4F8C31A0Q38915687-957FEFB0-64CD-4D9A-B963-82572E01FE81Q41464704-314FD235-8889-4993-A938-DFD240301728Q42339767-6CAC19CC-6C23-4813-800D-59EA2E6AB1AFQ43198338-B7711A08-1F63-4C57-919B-331762BD3BDAQ44699178-717B0752-2156-447C-B16D-4F36EAC62E1CQ50751291-F746BFDB-8DC4-44D5-8083-444104187923
P2860
Safe use of hemodialysis for dabigatran removal before cardiac surgery.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Safe use of hemodialysis for dabigatran removal before cardiac surgery.
@en
Safe use of hemodialysis for dabigatran removal before cardiac surgery.
@nl
type
label
Safe use of hemodialysis for dabigatran removal before cardiac surgery.
@en
Safe use of hemodialysis for dabigatran removal before cardiac surgery.
@nl
prefLabel
Safe use of hemodialysis for dabigatran removal before cardiac surgery.
@en
Safe use of hemodialysis for dabigatran removal before cardiac surgery.
@nl
P2093
P2860
P356
P1476
Safe use of hemodialysis for dabigatran removal before cardiac surgery.
@en
P2093
Edward T Horn
George Sokos
Samuel C Baroody
Subbarao Elapavaluru
P2860
P356
10.1345/APH.1R081
P407
P577
2012-08-07T00:00:00Z